Cargando…

Comparison of anticancer activities of Korean Red Ginseng-derived fractions

BACKGROUND: Korean Red Ginseng (KRG) is an ethnopharmacological plant that is traditionally used to improve the body’s immune functions and ameliorate the symptoms of various diseases. However, the antitumorigenic effects of KRG and its underlying molecular and cellular mechanisms are not fully unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Kwang-Soo, Yi, Young-Su, Son, Young-Jin, Jeong, Deok, Sung, Nak Yoon, Aravinthan, Adithan, Kim, Jong-Hoon, Cho, Jae Youl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489769/
https://www.ncbi.nlm.nih.gov/pubmed/28701882
http://dx.doi.org/10.1016/j.jgr.2016.11.001
_version_ 1783246857910091776
author Baek, Kwang-Soo
Yi, Young-Su
Son, Young-Jin
Jeong, Deok
Sung, Nak Yoon
Aravinthan, Adithan
Kim, Jong-Hoon
Cho, Jae Youl
author_facet Baek, Kwang-Soo
Yi, Young-Su
Son, Young-Jin
Jeong, Deok
Sung, Nak Yoon
Aravinthan, Adithan
Kim, Jong-Hoon
Cho, Jae Youl
author_sort Baek, Kwang-Soo
collection PubMed
description BACKGROUND: Korean Red Ginseng (KRG) is an ethnopharmacological plant that is traditionally used to improve the body’s immune functions and ameliorate the symptoms of various diseases. However, the antitumorigenic effects of KRG and its underlying molecular and cellular mechanisms are not fully understood in terms of its individual components. In this study, in vitro and in vivo antitumorigenic activities of KRG were explored in water extract (WE), saponin fraction (SF), and nonsaponin fraction (NSF). METHODS: In vitro antitumorigenic activities of WE, SF, and NSF of KRG were investigated in the C6 glioma cell line using cytotoxicity, migration, and proliferation assays. The underlying molecular mechanisms of KRG fractions were determined by examining the signaling cascades of apoptotic cell death by semiquantitative reverse transcriptase polymerase chain reaction and Western blot analysis. The in vivo antitumorigenic activities of WE, SF, and NSF were investigated in a xenograft mouse model. RESULTS: SF induced apoptotic death of C6 glioma cells and suppressed migration and proliferation of C6 glioma cells, whereas WE and NSF neither induced apoptosis nor suppressed migration of C6 glioma cells. SF downregulated the expression of the anti-apoptotic gene B-cell lymphoma-2 (Bcl-2) and upregulated the expression of the pro-apoptotic gene Bcl-2-associated X protein (BAX) in C6 glioma cells but had no effect on the expression of the p53 tumor-suppressor gene. Moreover, SF treatment resulted in activation of caspase-3 as evidenced by increased levels of cleaved caspase-3. Finally, WE, SF, and NSF exhibited in vivo antitumorigenic activities in the xenograft mouse model by suppressing the growth of grafted CT-26 carcinoma cells without decreasing the animal body weight. CONCLUSION: These results suggest that WE, SF, and NSF of KRG are able to suppress tumor growth via different molecular and cellular mechanisms, including induction of apoptosis and activation of immune cells.
format Online
Article
Text
id pubmed-5489769
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54897692017-07-12 Comparison of anticancer activities of Korean Red Ginseng-derived fractions Baek, Kwang-Soo Yi, Young-Su Son, Young-Jin Jeong, Deok Sung, Nak Yoon Aravinthan, Adithan Kim, Jong-Hoon Cho, Jae Youl J Ginseng Res Research Article BACKGROUND: Korean Red Ginseng (KRG) is an ethnopharmacological plant that is traditionally used to improve the body’s immune functions and ameliorate the symptoms of various diseases. However, the antitumorigenic effects of KRG and its underlying molecular and cellular mechanisms are not fully understood in terms of its individual components. In this study, in vitro and in vivo antitumorigenic activities of KRG were explored in water extract (WE), saponin fraction (SF), and nonsaponin fraction (NSF). METHODS: In vitro antitumorigenic activities of WE, SF, and NSF of KRG were investigated in the C6 glioma cell line using cytotoxicity, migration, and proliferation assays. The underlying molecular mechanisms of KRG fractions were determined by examining the signaling cascades of apoptotic cell death by semiquantitative reverse transcriptase polymerase chain reaction and Western blot analysis. The in vivo antitumorigenic activities of WE, SF, and NSF were investigated in a xenograft mouse model. RESULTS: SF induced apoptotic death of C6 glioma cells and suppressed migration and proliferation of C6 glioma cells, whereas WE and NSF neither induced apoptosis nor suppressed migration of C6 glioma cells. SF downregulated the expression of the anti-apoptotic gene B-cell lymphoma-2 (Bcl-2) and upregulated the expression of the pro-apoptotic gene Bcl-2-associated X protein (BAX) in C6 glioma cells but had no effect on the expression of the p53 tumor-suppressor gene. Moreover, SF treatment resulted in activation of caspase-3 as evidenced by increased levels of cleaved caspase-3. Finally, WE, SF, and NSF exhibited in vivo antitumorigenic activities in the xenograft mouse model by suppressing the growth of grafted CT-26 carcinoma cells without decreasing the animal body weight. CONCLUSION: These results suggest that WE, SF, and NSF of KRG are able to suppress tumor growth via different molecular and cellular mechanisms, including induction of apoptosis and activation of immune cells. Elsevier 2017-07 2017-01-05 /pmc/articles/PMC5489769/ /pubmed/28701882 http://dx.doi.org/10.1016/j.jgr.2016.11.001 Text en © 2017 The Korean Society of Ginseng, Published by Elsevier Korea LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Baek, Kwang-Soo
Yi, Young-Su
Son, Young-Jin
Jeong, Deok
Sung, Nak Yoon
Aravinthan, Adithan
Kim, Jong-Hoon
Cho, Jae Youl
Comparison of anticancer activities of Korean Red Ginseng-derived fractions
title Comparison of anticancer activities of Korean Red Ginseng-derived fractions
title_full Comparison of anticancer activities of Korean Red Ginseng-derived fractions
title_fullStr Comparison of anticancer activities of Korean Red Ginseng-derived fractions
title_full_unstemmed Comparison of anticancer activities of Korean Red Ginseng-derived fractions
title_short Comparison of anticancer activities of Korean Red Ginseng-derived fractions
title_sort comparison of anticancer activities of korean red ginseng-derived fractions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489769/
https://www.ncbi.nlm.nih.gov/pubmed/28701882
http://dx.doi.org/10.1016/j.jgr.2016.11.001
work_keys_str_mv AT baekkwangsoo comparisonofanticanceractivitiesofkoreanredginsengderivedfractions
AT yiyoungsu comparisonofanticanceractivitiesofkoreanredginsengderivedfractions
AT sonyoungjin comparisonofanticanceractivitiesofkoreanredginsengderivedfractions
AT jeongdeok comparisonofanticanceractivitiesofkoreanredginsengderivedfractions
AT sungnakyoon comparisonofanticanceractivitiesofkoreanredginsengderivedfractions
AT aravinthanadithan comparisonofanticanceractivitiesofkoreanredginsengderivedfractions
AT kimjonghoon comparisonofanticanceractivitiesofkoreanredginsengderivedfractions
AT chojaeyoul comparisonofanticanceractivitiesofkoreanredginsengderivedfractions